11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Population-based cancer statistics, including histology-specific incidence, prevalence, and survival are essential to evaluating the total burden due to disease in a population. The National Cancer Institute's (NCI) Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) was developed to better understand tumor biology and patient outcomes for 12 selected brain and other central nervous system (CNS) tumor histologies that are rare in adults to improve approaches to care and treatment. The aim of this study was to determine the incidence, prevalence, and survival of these selected rare histologies.

          Related collections

          Author and article information

          Journal
          J. Neurooncol.
          Journal of neuro-oncology
          Springer Science and Business Media LLC
          1573-7373
          0167-594X
          Aug 2019
          : 144
          : 1
          Affiliations
          [1 ] Central Brain Tumor Registry of the United States, Hinsdale, IL, USA.
          [2 ] Case Comprehensive Cancer Center, Cleveland, OH, USA.
          [3 ] Department of Bioethics, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
          [4 ] Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
          [5 ] Case Western Reserve University School of Medicine, Cleveland, OH, USA.
          [6 ] Department of Medicine, Section of Epidemiology and Population Sciences, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
          [7 ] Neuro Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
          [8 ] Central Brain Tumor Registry of the United States, Hinsdale, IL, USA. jsb42@case.edu.
          [9 ] Case Comprehensive Cancer Center, Cleveland, OH, USA. jsb42@case.edu.
          [10 ] Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA. jsb42@case.edu.
          Article
          10.1007/s11060-019-03215-x
          10.1007/s11060-019-03215-x
          31209773
          68c563fa-954b-485d-8a75-4ae77e6826f5
          History

          Prevalence,Survival,Rare tumors,Incidence,CNS tumors
          Prevalence, Survival, Rare tumors, Incidence, CNS tumors

          Comments

          Comment on this article